Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children

Vaccine

Volumn 29, Issue 26, 2011, Pages 4400-4404

  Tocheva, Anna S ^a   Jefferies, Johanna M C ^a,b,c   Rubery, Henry ^a   Bennett, Jessica ^a   Afimeke, Geraldine ^d   Garland, Joanna ^b   Christodoulides, Myron ^a   Faust, Saul N ^a,c,d   Clarke, Stuart C ^a,b,c  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c University Hospital Southampton NHS Foundation Trust   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Pneumococcal conjugate vaccine; Streptococcus pneumoniae

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIUM CARRIER; CHILD; HUMAN; IMMUNIZATION; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TIME SERIES ANALYSIS; TREATMENT OUTCOME; UNITED KINGDOM;

CARRIER STATE; CHILD, PRESCHOOL; HUMANS; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VACCINES, CONJUGATE;

EID: 79957801341     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.004     Document Type: Article

References (28)

1. Gray B.M., Converse G.M., Dillon H.C. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis 1980, 142(December (6)):923-933.
2. Obaro S., Adegbola R. The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 2002, 51(February (2)):98-104.
3. WHO Estimated pneumococcal deaths and cases 2010, 24.02.2010 [cited 2010 29.05.2010]; Available from: http://www.who.int/immunization_monitoring/burden/Pneumo_hib_estimates/en/index2.html.
4. HPA Invasive pneumococcal disease incidence rate per 100,000 population by age grouping England and Wales, 1996-2005 2008, [cited 2010 29.03.2010]; Available from: http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1195733823380?p=1203409671876.
5. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003, 348(May (18)):1737-1746.
6. Ruckinger S., van der Linden M., Reinert R.R., von Kries R., Burckhardt F., Siedler A. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine 2009, 27(June (31)):4136-4141.
7. Harboe Z.B., Valentiner-Branth P., Benfield T.L., Christensen J.J., Andersen P.H., Howitz M., et al. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine 2010, 28(March (14)):2642-2647.
8. Miller E. Post-PCV serotype changes. 7th international symposium on pneumococci and pneumococcal diseases 2010.
9. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 2007, 196(November (9)):1346-1354.
10. HPA Current epidemiology of invasive pneumococcal disease (IPD) 2010, [cited 07/11/2010]; Available from: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Pneumococcal/EpidemiologicalDataPneumococcal/CurrentEpidemiologyPneumococcal/InPrevenar7/.
11. HPA, Kaye P, Rashmi M, Martin S, Slack M, Trotter C, et al. Invasive pneumococcal disease (IPD) in England & Wales after 7-valent conjugate vaccine (PCV7); potential impact of 10 and 13-valent vaccines, [cited 2010 29.05.2010]; Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1245581527892.
12. Gray B.M., Turner M.E., Dillon H.C. Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am J Epidemiol 1982, 116(October (4)):692-703.
13. Lakshman R., Murdoch C., Race G., Burkinshaw R., Shaw L., Finn A. Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. Arch Dis Child 2003, 88(March (3)):211-214.
14. Hussain M., Melegaro A., Pebody R.G., George R., Edmunds W.J., Talukdar R., et al. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect 2005, 133(October (5)):891-898.
15. Pai R., Gertz R.E., Beall B. Sequential multiplex PCR Approach for Determining Capsular Serotypes of Streptococcus pneumoniae Isolates. J Clin Microbiol 2006, 44(January (1)):124-131.
16. CDC PCR deduction of pneumococcal serotypes 2010, 03.03.2010 [cited 2010 03.06.2010]; Available from: www.cdc.gov/ncidod/biotech/strep/pcr.htm.
17. Bland M. An introduction to medical statistics 2000, Oxford University Press. 3rd ed.
18. Tocheva A.S., Jefferies J.M., Christodoulides M., Faust S.N., Clarke S.C. Increase in serotype 6C pneumococcal carriage, United Kingdom. Emerg Infect Dis 2010, 16(January (1)):154-155.
19. Sa-Leao R., Nunes S., Brito-Avo A., Frazao N., Simoes A.S., Crisostomo M.I., et al. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect 2009, 15(November (11)):1002-1007.
20. Vestrheim D.F., Hoiby E.A., Aaberge I.S., Caugant D.A. Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway. Clin Vaccine Immunol 2010, 17(March (3)):325-334.
21. Kellner J.D., Scheifele D., Vanderkooi O.G., Macdonald J., Church D.L., Tyrrell G.J. Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada. Pediatr Infect Dis J 2008, 27(June (6)):526-532.
22. Huang S.S., Platt R., Rifas-Shiman S.L., Pelton S.I., Goldmann D., Finkelstein J.A. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005, 116(September (3)):e408-e413.
23. Cooper D., Yu X., Sidhu M., Nahm M.H., Fernsten P., Jansen K.U. Development of an opsonophagocytic assay to Streptococcus pneumoniae serotype 6C: demonstration of cross-functional responses to 6C in Prevenar-13 immune sera. 28th annual meeting of the European society for paediatric infectious diseases 2010.
24. Kaye P, Rashmi M, Martin S, Slack M, Trotter C, Jit M, et al. Invasive pneumococcal disease (IPD) in England & Wales after 7-valent conjugate vaccine (PCV7); potential impact of 10 and 13-valent vaccines, [cited 2010 29.05.2010]; Available from: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1245581527892.
25. HPA. Current Epidemiology of Invasive Pneumococcal Disease (IPD)2010 [cited 03.06.2010]; Available from: http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Pneumococcal/EpidemiologicalDataPneumococcal/CurrentEpidemiologyPneumococcal/.
26. Yeh S.H., Gurtman A., Hurley D.C., Block S.L., Schwartz R.H., Patterson S., et al. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers. Pediatrics 2010, 126(September (3)):e493-e505.
27. NHS. NHS information centre for health and social care, [cited 2010 30.03.2010]; Available from: http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles/immunisation/.
28. Carvalho MdG, Pimenta F.C., Jackson D., Roundtree A., Ahmad Y., Millar E.V., et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol 2010, 48(May (5)):1611-1618.